Clinical trial
Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome
NCT00356733 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00356733 |
|---|---|
| Title | Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome |
| Official title | Mechanisms of Erythropoietin Action in the Cardiorenal Syndrome |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Dutch Heart Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive, Renal Insufficiency, Chronic |
| Intervention type | Drug |
| Interventions | Erythropoietin administration |
| Enrollment | 62 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Jul 26, 2006 |
| Last update posted | Dec 2, 2011 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: